4-Amino cyclohexylglycine analogues as potent dipeptidyl peptidase IV inhibitors

被引：43

作者：

Parmee, ER

He, JF

Mastracchio, A

Edmondson, SD

Colwell, L

Eiermann, G

Feeney, WP

Habulihaz, B

He, HB

Kilburn, R

Leiting, B

Lyons, K

Marsilio, F

Patel, RA

Petrov, A

Di Salvo, J

Wu, JK

Thornberry, NA

Weber, AE

机构：

[1] Merck & Co Inc, Dept Med Chem, Rahway, NJ 07065 USA

[2] Merck & Co Inc, Dept Metab Dis, Rahway, NJ 07065 USA

[3] Merck & Co Inc, Dept Anim Pharmacol, Rahway, NJ 07065 USA

[4] Merck & Co Inc, Dept Immunol & Rheumatol, Rahway, NJ 07065 USA

[5] Merck & Co Inc, Dept Comparat Med, Rahway, NJ 07065 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 01期

关键词：

D O I：

10.1016/j.bmcl.2003.10.016

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Substituted 4-amino cyclohexylglycine analogues were evaluated for DP-IV inhibitory properties. Bis-sulfonamide 15e was an extremely potent 2.6 nM inhibitor of the enzyme with excellent selectivity over all counterscreens. 2,4-Difluorobenzenesulfonamide 15b and 1-naphthyl amide 16b, however, combined an acceptable in vitro profile with good pharmacokinetic properties in the rat, and 15b was orally efficacious at 3 mpk in an OGTT in lean mice. (C) 2003 Elsevier Ltd. All rights reserved.

引用

页码：43 / 46

页数：4

共 50 条

[31] Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV
Tanaka, S
Murakami, T
Horikawa, H
Sugiura, M
Kawashima, K
Sugita, T
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1997, 19 (01): : 15 - 24
[32] Synthesis and evaluation of structurally constrained imidazolidin derivatives as potent dipeptidyl peptidase IV inhibitors
Wang, Liutang
Zhang, Bin
Ji, Jianxin
Li, Bogang
Yan, Jufang
Zhang, Weiyu
Wu, Yong
Wang, Xuechao
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (08) : 3318 - 3322
[33] Fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors
Caldwell, CG
Chen, P
He, JF
Parmee, ER
Leiting, B
Marsilio, F
Patel, RA
Wu, JK
Eiermann, GJ
Petrov, A
He, HB
Lyons, KA
Thornberry, NA
Weber, AE
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (05) : 1265 - 1268
[34] Recent patents of dipeptidyl peptidase IV inhibitors
Mendieta, Laura
Tarrago, Teresa
Giralt, Ernest
EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (11) : 1693 - 1741
[35] Dipeptidyl peptidase iv inhibitors and diabetes therapy
McIntosh, Christopher H. S.
FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 1753 - 1773
[36] CoMFA and CoMSIA of diverse pyrrolidine analogues as dipeptidyl peptidase IV inhibitors: active site requirements
Murugesan, Vanangamudi
Sethi, Nidhi
Prabhakar, Yenamandra S.
Katti, Seturam B.
MOLECULAR DIVERSITY, 2011, 15 (02) : 457 - 466
[37] Design, synthesis, and biological evaluation of triazolopiperazine-based β-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors
Kowalchick, Jennifer E.
Leiting, Barbara
Pryor, KellyAnn D.
Marsilio, Frank
Wu, Joseph K.
He, Huaibing
Lyons, Kathryn A.
Eiermann, George J.
Petrov, Aleksandr
Scapin, Giovanna
Patel, Reshma A.
Thornberry, Nancy A.
Weber, Ann E.
Kim, Dooseop
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (21) : 5934 - 5939
[38] CoMFA and CoMSIA of diverse pyrrolidine analogues as dipeptidyl peptidase IV inhibitors: active site requirements
Vanangamudi Murugesan
Nidhi Sethi
Yenamandra S. Prabhakar
Seturam B. Katti
Molecular Diversity, 2011, 15 : 457 - 466
[39] Fluropyrrolidines as novel, potent dipeptidyl peptidase inhibitors.
Randhawa, SA
Haffner, CD
Lenhard, JM
Osterhout, MH
Stephenson, B
Wright, LL
Croom, DK
Bass, JY
Caldwell, RD
Cowan, DJ
Deaton, DN
Dwornik, KA
Fang, J
Heyer, DO
Kaldor, IW
Larkin, AL
McConn, DJ
McDougald, DL
McFadyen, RB
Reister, SM
Secosky, MB
Thompson, BD
Wells-Knecht, KJ
Zhang, WH
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U17 - U17
[40] Design, Synthesis and SAR Studies of Novel and Potent Dipeptidyl Peptidase 4 Inhibitors
Luo, Na
Fang, Xiaoyu
Su, Mingbo
Zhang, Xinwen
Li, Dan
Li, Honglin
Li, Shiliang
Zhao, Zhenjiang
CHINESE JOURNAL OF CHEMISTRY, 2021, 39 (01): : 115 - 120

← 1 2 3 4 5 →